Skip to main content
. 2024 Dec 28;17(1):59. doi: 10.3390/cancers17010059

Figure 4.

Figure 4

Schematic representing a chemotherapeutic drug approach to targeting cancer stem cells (CSCs) as a potential treatment for cancer. Salinomycin has shown specific preclinical activity against CSCs. Reproduced with permission from https://www.mdpi.com/2673-8937/3/2/16 [91]. Accessed on 20 December 2024.